Back

Pro-adrenomedullin may guide decongestive therapy in acute heart failure patients

11 May 2024 (12:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - biomarkers 2 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Benedikt Norbert Beer

Karolinska Institute, Stockholm (Sweden)

6 More presentations in this session

Presentation thumbnail
Fibrosis-4 index may predict long-term mortality in patients admitted for acute decompensated heart failure
Associate Professor B. MURAT (Eskisehir, TR)
Abstract Slides Video
Presentation thumbnail
Proteomic profiles of left atrial volume and its influence on response to spironolactone: findings from the HOMAGE trial and STANISLAS cohort
Doctor M. Kobayashi (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Circulating levels of erythrocytes-derived vesicles related to poor glycaemia control in heart failure patients with type 2 diabetes mellitus
Professor A. Berezin (Salzburg, AT)
Abstract Slides Video
Presentation thumbnail
Increased serum PRO-C3 is associated with heart failure worsening in hypertensive patients with heart failure
Mr I. Latasa Amezqueta (Pamplona, ES)
Abstract Slides Video
Presentation thumbnail
Normal troponin T and NTproBNP values effectively rule-out cardiac amyloidosis in patients with prior bilateral surgery for carpal tunnel syndrome.
Doctor N. Noory (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - biomarkers 2

The Event

Event poster

Heart Failure 2024

11 May 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Bio-ADM as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure; data from STRONG-HF
thumbnail
Congress Session
Decongestion in acute heart failure (1)
thumbnail
Congress Presentation
Prognostic assessment of the combination of subclinical congestion parameters in worsening heart failure events and 90-day mortality

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources